Souri Z, Pakdel F
J Ophthalmic Vis Res. 2024; 19(3):368-380.
PMID: 39359534
PMC: 11443990.
DOI: 10.18502/jovr.v19i3.15047.
Grixti L, Lane L, Pearce S
Rev Endocr Metab Disord. 2023; 25(1):203-214.
PMID: 38108994
PMC: 10808215.
DOI: 10.1007/s11154-023-09848-8.
Vargas-Uricoechea H
Cells. 2023; 12(6).
PMID: 36980259
PMC: 10047067.
DOI: 10.3390/cells12060918.
Chera A, Stancu A, Bucur O
Front Endocrinol (Lausanne). 2022; 13:1010279.
PMID: 36204105
PMC: 9530140.
DOI: 10.3389/fendo.2022.1010279.
Shahida B, Tsoumani K, Planck T, Modhukur V, Asp P, Sundlov A
Endocrine. 2021; 75(3):856-864.
PMID: 34859391
PMC: 8888513.
DOI: 10.1007/s12020-021-02952-2.
Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease.
Chau C, Shih K, Chow L, Lee V
Ophthalmol Ther. 2020; 10(1):5-12.
PMID: 33146864
PMC: 7886920.
DOI: 10.1007/s40123-020-00317-y.
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.
Schnell A, Bod L, Madi A, Kuchroo V
Cell Res. 2020; 30(4):285-299.
PMID: 31974523
PMC: 7118128.
DOI: 10.1038/s41422-020-0277-x.
The potential role for infections in the pathogenesis of autoimmune Addison's disease.
Hellesen A, Bratland E
Clin Exp Immunol. 2018; 195(1):52-63.
PMID: 30144040
PMC: 6300649.
DOI: 10.1111/cei.13207.
CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function.
Chen Y, Chen S, Gu Y, Feng Y, Shi Y, Fu Q
Sci Rep. 2018; 8(1):10074.
PMID: 29973665
PMC: 6031668.
DOI: 10.1038/s41598-018-28423-9.
Association between rs3087243 and rs231775 polymorphism within the cytotoxic T-lymphocyte antigen 4 gene and Graves' disease: a case/control study combined with meta-analyses.
Tu Y, Fan G, Dai Y, Zeng T, Xiao F, Chen L
Oncotarget. 2018; 8(66):110614-110624.
PMID: 29299173
PMC: 5746408.
DOI: 10.18632/oncotarget.22702.
General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.
Xiaoheng C, Yizhou M, Bei H, Huilong L, Xin W, Rui H
Mediators Inflamm. 2017; 2017:3916395.
PMID: 28133421
PMC: 5241475.
DOI: 10.1155/2017/3916395.
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.
McKinney E, Smith K
Immunol Cell Biol. 2016; 94(10):935-942.
PMID: 27577866
DOI: 10.1038/icb.2016.81.
A powerful test of independent assortment that determines genome-wide significance quickly and accurately.
Stewart W, Hager V
Heredity (Edinb). 2016; 117(2):109-13.
PMID: 27245422
PMC: 4949729.
DOI: 10.1038/hdy.2016.33.
Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
Ting W, Chien M, Lo F, Wang C, Huang C, Lin C
PLoS One. 2016; 11(4):e0154394.
PMID: 27111218
PMC: 4844099.
DOI: 10.1371/journal.pone.0154394.
Association of the gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease.
Fang W, Zhang Z, Zhang J, Cai Z, Zeng H, Chen M
Biomed Rep. 2015; 3(5):691-696.
PMID: 26405547
PMC: 4576490.
DOI: 10.3892/br.2015.493.
CTLA-4 as a genetic determinant in autoimmune Addison's disease.
Wolff A, Mitchell A, Cordell H, Short A, Skinningsrud B, Ollier W
Genes Immun. 2015; 16(6):430-6.
PMID: 26204230
PMC: 4561510.
DOI: 10.1038/gene.2015.27.
Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy.
Pawlowski P, Wawrusiewicz-Kurylonek N, Eckstein A, Reszec J, Luczynski W, Johnson K
Mediators Inflamm. 2015; 2015:340934.
PMID: 25653477
PMC: 4306377.
DOI: 10.1155/2015/340934.
Associations of CTLA4 Gene Polymorphisms with Graves' Ophthalmopathy: A Meta-Analysis.
Du P, Ma X, Wang C
Int J Genomics. 2014; 2014:537969.
PMID: 25121088
PMC: 4121157.
DOI: 10.1155/2014/537969.
Immunoglobulin heavy chain variable region and major histocompatibility region genes are linked to induced graves' disease in females from two very large families of recombinant inbred mice.
McLachlan S, Aliesky H, Banuelos B, Magana J, Williams R, Rapoport B
Endocrinology. 2014; 155(10):4094-103.
PMID: 25051451
PMC: 4164918.
DOI: 10.1210/en.2014-1388.
Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal.
Wang P, Chen I, Juo S, Hsi E, Liu R, Hsieh C
Eur Thyroid J. 2014; 1(4):251-8.
PMID: 24783027
PMC: 3821483.
DOI: 10.1159/000342621.